Table 2 Patient plasma fatty acid panel
Fatty acid | Patient value (nmol/mL) | Reference value (nmol/mL) |
|---|---|---|
8:0 (Octanoic acid) | 5 | 8–47 |
10:1 (Decenoic acid) | 1.6 | 1.8–5.0 |
10:0 (Decanoic acid) | 8 | 2–18 |
12:1 (Lauroleic acid) | 2.2 | 1.4–6.6 |
12:0 (Lauric acid) | 32 | 6–90 |
14:2 (Tetradecadlenoic acid) | 1.0 | 0.8–5.0 |
14:1 (Myristoleic acid) | 5 | 3–64 |
14:0 (Myristic acid) | 77 | 30–150 |
16:2 (Hexadecadienoic acid) | 8 | 10–48 |
16:1w9 (Hexadecenoic acid) | 56 | 25–105 |
16:1w7 (Palmitoleic acid) | 171 | 110–1130 |
16:0 (Palmitic acid) | 2307 | 1480–3730 |
18:3w9 (g-Linoleic acid) | 14 | 16–150 |
18:3w3 (a-Linoleic acid) | 40 | 50–130 |
18:2w6 (Linoleic acid) | 2854 | 2270–3850 |
18:1w9 (Oleic acid) | 1893 | 650–3500 |
18:1w7 (Vaccenic acid) | 341 | 280–740 |
18:0 (Stearic acid) | 712 | 590–1170 |
20:5w3 (EPA) | 29 | 14–100 |
20:4w6 (Arachidonic acid) | 1555 | 520–1490 |
20:3w9 (Mead acid) | 87 | 7–30 |
20:3w6 (h-g-Linolenic acid) | 166 | 50–250 |
20:0 (Arachidic acid) | 42 | 50–90 |
22:6w3 (DHA) | 318 | 30–250 |
22:5w6 (DPA) | 43 | 10–70 |
22:5w3 (DPA) | 125 | 20–210 |
22:4w6 (DTA) | 77 | 10–80 |
22:1 (Docosenoic acid) | 10 | 4–13 |
22:0 (Docosanoic acid) | 50.8 | 0.0–96.3 |
24:1w9 (Nervonic acid) | 119 | 60–100 |
24:0 (Tetracosanoic acid) | 40.8 | 0.0–91.4 |
26:1 (Hexacosanoic acid) | 0.7 | 0.3–0.7 |
26:0 (Hexacosanoic acid) | 0.48 | 0.00–1.30 |
15:0(CH3)4 (Pristanic acid) | 0.09 | 0.00–2.98 |
16:0(CH3)4 (Phytanic acid) | 0.88 | 0.00–9.88 |
Total Fatty Acids | 11.2 mmol/L | 7.3–16.8 mmol/L |